We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in AVANIR PHARMACEUTICALS, INC CL A in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 163 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 166 → 0 (-166)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.74B → $0 (-$2.74B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 163

Holders
–
Holders Change
-166
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
163
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$653M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$398M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$152M
4
BFA
BlackRock Fund Advisors
California
-$146M
5
WIC
Water Island Capital
New York
-$89.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
101
BlueCrest Capital Management
Jersey
– -$1.02M -60,114 Closed
BG
102
BlackRock Group
United Kingdom
– -$1M -59,292 Closed
Credit Agricole
103
Credit Agricole
France
– -$918K -54,150 Closed
NIT
104
NumerixS Investment Technologies
British Columbia, Canada
– -$892K -52,600 Closed
VAM
105
Visium Asset Management
New York
– -$873K -51,419 Closed
SMC
106
S. Muoio & Co
New York
– -$848K -50,000 Closed
FNYS
107
First New York Securities
New York
– -$838K -49,446 Closed
TI
108
Telemetry Investments
New York
– -$818K -48,263 Closed
D.E. Shaw & Co
109
D.E. Shaw & Co
New York
– -$712K -42,000 Closed
TSS
110
Two Sigma Securities
New York
– -$654K -38,606 Closed
DC
111
Deere & Company
Illinois
– -$652K -38,450 Closed
STIA
112
Stone Toro Investment Advisers
New Jersey
– -$610K -36,000 Closed
Principal Financial Group
113
Principal Financial Group
Iowa
– -$608K -35,890 Closed
Public Employees Retirement Association of Colorado
114
Public Employees Retirement Association of Colorado
Colorado
– -$604K -35,622 Closed
Wells Fargo
115
Wells Fargo
California
– -$597K -35,179 Closed
TC
116
TFS Capital
Pennsylvania
– -$583K -34,424 Closed
PPA
117
Parametric Portfolio Associates
Washington
– -$580K -34,192 Closed
AW
118
Alpha Windward
Massachusetts
– -$554K -32,700 Closed
O
119
OppenheimerFunds
New York
– -$552K -32,549 Closed
SO
120
STRS Ohio
Ohio
– -$551K -32,500 Closed
AG
121
Aperio Group
California
– -$548K -32,305 Closed
MC
122
Menta Capital
California
– -$464K -27,400 Closed
CCA
123
Catalyst Capital Advisors
New York
– -$424K -25,000 Closed
CPA
124
Cowen Prime Advisors
New York
– -$424K -25,000 Closed
HM
125
Harvest Management
New York
– -$424K -25,000 Closed
3 4
5
6 7

AVNR Hedge Fund Activity: Q1 2015 in Review

0 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q1 2015, worth a combined $0 — down 100% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 163 funds closed out of AVNR and 0 opened new positions — a net loss of 163 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $653M sold.

  • 0 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q1 2015, down from 166 in Q4 2014.
  • Funds reported $0 of AVANIR PHARMACEUTICALS, INC CL A stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q1 2015 and 163 closed out, a net change of -163 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q1 2015 was Baker Bros. Advisors, an estimated $653M sold.

Based on aggregated 13F filings for Q1 2015.